Position in ACAD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$41,069,692
+$803,646 QoQ
Shares Held
1,623,308
+7.7% QoQ
Ownership
0.942%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 354 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. ACAD ranks #29 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in ACAD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,069,692 | 1,623,308 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $40,266,046 | 1,507,527 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $31,678,715 | 1,468,647 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $23,596,348 | 1,420,611 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $25,554,540 | 1,392,618 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $20,492,511 | 1,332,413 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $23,586,598 | 1,451,483 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $28,072,534 | 1,518,255 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $45,187,155 | 1,443,218 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $25,129,247 | 1,205,818 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $34,219,376 | 1,428,784 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $38,052,402 | 2,021,913 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $31,110,163 | 1,954,156 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $32,346,272 | 1,977,156 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $23,463,555 | 1,665,263 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $29,117,259 | 1,202,199 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $25,165,164 | 1,078,199 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $21,931,827 | 1,320,399 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $28,719,127 | 1,177,496 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $21,998,911 | 852,671 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $58,406,760 | 1,092,532 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $55,836,742 | 1,353,618 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $62,341,483 | 1,286,187 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $56,678,544 | 1,341,504 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||